3rd Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$1,980,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

18 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicaid Rebates Dual Eligibles Generic Fill Incentives Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590:(Senate) Patient Protection and Affordable Care Act Reimbursement Issues Funding for National Institutes of Health S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review S. 1584: Drug Safety and Accountability Act of 2011 Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Biodefense Research, Development and Procurement (Non-Funding Issues) Pandemic and All-Hazards Preparedness Act Reauthorization HHS Countermeasures Review Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Policies and Regulation

Contacted: Centers For Disease Control & Prevention (CDC); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Energy, Dept of; Defense, Dept of (DOD); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); SENATE; Navy, Dept of; State, Dept of (DOS); Treasury, Dept of; Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Bills named: S. 296 (112th), H.R. 2245 (112th), H.R. 2112 (112th), H.R. 3590 (112th), S. 1584 (112th), S. 1599 (112th)

Agriculture AGR

Biomass Crop Assistance Program (BCAP) Funding H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems EPA Regulations on Agricultural Biotechnology EPA Notice on PIP Data Requirements Reauthorization and Implementation of Pesticide Registration Improvement Act Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon FDA Approval Labeling Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Codex Standards TransPacific Partnership Sanitary and Phytosanitary Issues Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement Discussions with EU on Animal Cloning China Biotechnology Regulations Low-Level Presence Foreign Government Polices European Union Low-Level Presence Policy EU Biotechnology Bilateral Discussions Korea Biotechnology Regulations APEC Agricultural Biotechnology Discussions Regulatory Actions on Biological Pesticides H.R. 872: Reducing Regulatory Burdens Act of 2011 Agricultural Biotechnology Regulatory Reform and Modernization House Agriculture Subcommittee Hearings Potential Regulation of New Genetic Modification Technologies EU Workshop

LobbyistCovered position, as disclosed
AB BASU —
BRENT ALAN DELMONTE —
DAVID EDWARDS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —

Contacted: State, Dept of (DOS); Navy, Dept of; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Office of Science & Technology Policy (OSTP); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Energy, Dept of; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); SENATE; Treasury, Dept of; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 872 (112th), H.R. 2112 (112th)

Taxation/Internal Revenue Code TAX

Bio-based Products Tax Credit Therapeutic Discovery Project Tax Credit Extension Biofuels Investment Tax Credit Options Biofuels Production Tax Credit Modification for Algae-based Biofuels Biofuels Production Tax Credit Extension Capital Formation Investment Incentives Expansion of Eligibility under SEC Regulation A H.R. 1070: The Small Company Capital Formation Act

Contacted: U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Treasury, Dept of; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC); State, Dept of (DOS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); SENATE; Centers For Disease Control & Prevention (CDC); Navy, Dept of; Executive Office of the President (EOP); Energy, Dept of

Bills named: H.R. 1070 (112th)

Science/Technology SCI

Small Business Innovation and Research (SBIR) Program Reauthorization HR 1425: Creating Jobs Through Small Business Innovation Act of 2011 S.493: SBIR/STTR Reauthorization Act of 2011

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
ALAN EISENBERG —
ELIZABETH CARTIER ESHAM —
CHARLES H FRITTS New —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Treasury, Dept of; Navy, Dept of; Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); Energy, Dept of; Defense, Dept of (DOD); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Executive Office of the President (EOP); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); Office of Science & Technology Policy (OSTP)

Bills named: S. 493 (112th), H.R. 1425 (112th)

Clean Air and Water (quality) CAW

IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal)

LobbyistCovered position, as disclosed
MATT CARR —
SARAH THORNTON CASWELL —
DANA MAURICE O'BRIEN —
ROY STANFORD ZWAHLEN —

Contacted: Commerce, Dept of (DOC); Energy, Dept of; State, Dept of (DOS); Environmental Protection Agency (EPA); Treasury, Dept of; Executive Office of the President (EOP); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Defense, Dept of (DOD); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Navy, Dept of; Patent & Trademark Office (PTO)

Consumer Issues/Safety/Products CSP

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems Genetically Engineered (GE) Animals FDA Approval Labeling H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon Generic Drug Patent Settlements Drug Safety and Review S. 1584: Drug Safety and Accountability Act of 2011 Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011

Contacted: Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Energy, Dept of; Food & Drug Administration (FDA); Treasury, Dept of; SENATE; Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Navy, Dept of; Securities & Exchange Commission (SEC); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Executive Office of the President (EOP)

Bills named: S. 296 (112th), H.R. 2112 (112th), S. 1584 (112th), H.R. 2245 (112th)

Trade (domestic/foreign) TRD

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Codex Standards Intellectual Property International Enforcement TransPacific Partnership Sanitary and Phytosanitary Issues Data and Intellectual Property for Pharmaceuticals Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement Discussions with EU on Animal Cloning China Biotechnology Regulations Low-Level Presence Foreign Government Policies European Union Low Level Presence Policy EU Biotechnology Bilateral Discussions Korea Biotechnology Regulations APEC Agricultural Biotechnology Discussions Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Philippines IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Potential Regulation of New Genetic Modification Technologies EU Workshop

Contacted: SENATE; U.S. Trade Representative (USTR); Treasury, Dept of; Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Energy, Dept of; Executive Office of the President (EOP); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Navy, Dept of; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Patent Reform H.R. 1249: The Leahy-Smith America Invents Act of 2011 S. 23: The Patent Reform Act of 2011 Implementation of H.R. 1249: The America Invents Act of 2011 IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Generic Drug Patent Settlements Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Philippines DNA Patenting and Licensing Rep. Wasserman Schultz Amendment to H.R. 1249: The America Invents Act of 2011 Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Domestic Manufacturing Requirement Intellectual Property International Enforcement TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals

Contacted: Securities & Exchange Commission (SEC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Energy, Dept of; Agriculture, Dept of (USDA); Treasury, Dept of; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); State, Dept of (DOS); Food & Drug Administration (FDA); Defense, Dept of (DOD); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); SENATE; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Navy, Dept of

Bills named: H.R. 1249 (112th), S. 23 (112th)

Small Business SMB

Capital Formation Investment Incentives Sarbanes Oxley Section 404 (b) Exemption Small Company Job Growth and Regulatory Relief Act of 2011 (Discussion Draft) Small Business Innovation and Research (SBIR) Program Reauthorization HR 1425: Creating Jobs through Small Business Innovation Act of 2011 S.493: SBIR/STTR Reauthorization Act of 2011 Small Business Early-Stage Investment Therapeutic Discovery Project Tax Credit Extension Expansion of Eligibility under SEC Regulation A H.R. 1070: The Small Company Capital Formation Act

Contacted: Treasury, Dept of; Securities & Exchange Commission (SEC); Energy, Dept of; HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); State, Dept of (DOS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC); Navy, Dept of; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 1425 (112th), S. 493 (112th), H.R. 1070 (112th)

Medicare/Medicaid MMM

Medicaid Rebates Dual Eligibles Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Policies and Regulation

Contacted: Navy, Dept of; HOUSE OF REPRESENTATIVES; Energy, Dept of; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Defense, Dept of (DOD); Securities & Exchange Commission (SEC); State, Dept of (DOS); Treasury, Dept of; SENATE; U.S. Trade Representative (USTR); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 3590 (112th)

Budget/Appropriations BUD

Funding for Biomass Crop Assistance Program (BCAP) H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for FY 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for FY 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for National Institutes of Health Cures Acceleration Network S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon

Contacted: Agriculture, Dept of (USDA); SENATE; Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Navy, Dept of; U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Energy, Dept of; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Treasury, Dept of; Executive Office of the President (EOP); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Defense, Dept of (DOD); Commerce, Dept of (DOC)

Bills named: H.R. 2219 (112th), H.R. 2354 (112th), H.R. 2112 (112th)

Energy/Nuclear ENG

Renewable Fuels Standard S.1564: The Renewable Fuel Parity Act of 2011 Biofuels Economic Growth Impact/Potential of Advanced Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Investment Tax Credit Options DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels Next Generation Incentives : Farm Bill Reauthorization Biofuels Production Tax Credit Extension Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Bio-based Products Expansion of DOE and USDA Loan Guarantee Programs Next Generation Incentives: Farm Bill Reauthorization USDA BioPreferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Tax Credit Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Renewable Chemicals Farm Bill Reauthorization: DOE Loan Guarantees

LobbyistCovered position, as disclosed
MATT CARR —
SARAH THORNTON CASWELL —
BRENT ALAN DELMONTE —
CHARLES H FRITTS New —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: SENATE; Agriculture, Dept of (USDA); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Defense, Dept of (DOD); Energy, Dept of; Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Navy, Dept of; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Treasury, Dept of; State, Dept of (DOS); Food & Drug Administration (FDA)

Bills named: H.R. 2219 (112th), S. 1564 (112th), H.R. 2354 (112th)

Food Industry (safety, labeling, etc.) FOO

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon FDA Approval Labeling

LobbyistCovered position, as disclosed
AB BASU —
BRENT ALAN DELMONTE —
DAVID EDWARDS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —

Contacted: Commerce, Dept of (DOC); Environmental Protection Agency (EPA); State, Dept of (DOS); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Treasury, Dept of; Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Navy, Dept of; Energy, Dept of; Defense, Dept of (DOD); SENATE; Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC)

Bills named: H.R. 2112 (112th)

Animals ANI

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE salmon FDA Approval Labeling

LobbyistCovered position, as disclosed
AB BASU —
BRENT ALAN DELMONTE —
DAVID EDWARDS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —

Contacted: Commerce, Dept of (DOC); Centers For Disease Control & Prevention (CDC); Agriculture, Dept of (USDA); State, Dept of (DOS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); SENATE; Energy, Dept of; Executive Office of the President (EOP); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Treasury, Dept of; Defense, Dept of (DOD); Navy, Dept of; Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2112 (112th)

Pharmacy PHA

Medicaid Rebates Dual Eligibles Generic Fill Incentives Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Navy, Dept of; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); Executive Office of the President (EOP); SENATE; Energy, Dept of; Patent & Trademark Office (PTO); Treasury, Dept of; State, Dept of (DOS); Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); Defense, Dept of (DOD); Commerce, Dept of (DOC); Food & Drug Administration (FDA)

Bills named: H.R. 3590 (112th), H.R. 2245 (112th), S. 296 (112th)

Medical/Disease Research/Clinical Labs MED

Cures Acceleration Network S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Funding for National Institutes of Health S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Rare Pediatric & Tropical Disease Drug Development Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement (Non-Funding Issues) Pandemic and All-Hazards Preparedness Act Reauthorization HHS Countermeasures Review

Contacted: U.S. Trade Representative (USTR); Executive Office of the President (EOP); Securities & Exchange Commission (SEC); SENATE; State, Dept of (DOS); Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Energy, Dept of; Environmental Protection Agency (EPA); Treasury, Dept of; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Navy, Dept of

Fuel/Gas/Oil FUE

Renewable Fuels Standard S.1564: The Renewable Fuel Parity Act of 2011 Biofuels Economic Growth Impact/Potential of Advanced Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Investment Tax Credit Options DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels Next Generation Incentives : Farm Bill Reauthorization Biofuels Production Tax Credit Extension Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Bio-based Products Expansion of DOE and USDA Loan Guarantee Programs Next Generation Incentives: Farm Bill Reauthorization USDA BioPreferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Tax Credit Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Renewable Chemicals Farm Bill Reauthorization: DOE Loan Guarantees

LobbyistCovered position, as disclosed
MATT CARR —
SARAH THORNTON CASWELL —
BRENT ALAN DELMONTE —
CHARLES H FRITTS New —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: Navy, Dept of; Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); SENATE; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Energy, Dept of; Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); State, Dept of (DOS); Treasury, Dept of

Bills named: H.R. 2219 (112th), S. 1564 (112th), H.R. 2354 (112th)

Homeland Security HOM

Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012

LobbyistCovered position, as disclosed
PHYLLIS ARTHUR —
MELISSA BOWIE —
BRENT ALAN DELMONTE —
TOM DILENGE —
JEANNE HAGGERTY —
TRACEY LATURNER —
ANNA KATHERINE WEINSTEIN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; Treasury, Dept of; Patent & Trademark Office (PTO); Executive Office of the President (EOP); Navy, Dept of; Centers For Disease Control & Prevention (CDC); Securities & Exchange Commission (SEC); Energy, Dept of; Agriculture, Dept of (USDA); Defense, Dept of (DOD); Commerce, Dept of (DOC); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.